Health Care  |  Pharmaceuticals
53.79 0.38 0.71%
Stock Price | May 25, 2022, 4 p.m.
Bid: 53.65
Ask: 53.74
Prev. Close: 53.41
52 Week Low: 38.475
52 Week High: 61.71
PE Ratio: 12.096847
Dividend Yield: 298.0%

Company Summary

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Read more Read less

Recently Viewed Tickers